John D. Grainger

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

UK Experience of Children With Inhibitors in Severe Haemophilia B: A Report by the UKHCDO Paediatric Working Party.

UK Experience of Children With Inhibitors in Severe Haemophilia B: A Report by the UKHCDO Paediatric Working Party.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 06, 2026

Avatrombopag for persistent and chronic immune thrombocytopenia in children: A post hoc analysis of clinical characteristics of response from a phase 3b clinical trial.

Avatrombopag for persistent and chronic immune thrombocytopenia in children: A post hoc analysis of clinical characteristics of response from a phase 3b clinical trial.

Journal: British journal of haematology

Published: February 23, 2026

Can machine learning identify inherited causes of thrombocytopenia? A feasibility study.

Can machine learning identify inherited causes of thrombocytopenia? A feasibility study.

Journal: British journal of haematology

Published: January 09, 2026

Avatrombopag for treating children and adolescents with immune thrombocytopenia: a plain language summary.

Avatrombopag for treating children and adolescents with immune thrombocytopenia: a plain language summary.

Journal: Expert review of hematology

Published: December 18, 2025

Diagnostic Performance of Prothrombin Time and Activated Partial Thromboplastin Time in Children: A Service Evaluation.

Diagnostic Performance of Prothrombin Time and Activated Partial Thromboplastin Time in Children: A Service Evaluation.

Journal: International journal of laboratory hematology

Published: June 18, 2025

Integration of unpaired and heterogeneous clinical flow cytometry data.

Integration of unpaired and heterogeneous clinical flow cytometry data.

Journal: iScience

Published: February 12, 2025

Safe and Efficacious Use of Low-Dose Rituximab in Postpubertal Paediatric Patients With Immune Thrombocytopenia.

Safe and Efficacious Use of Low-Dose Rituximab in Postpubertal Paediatric Patients With Immune Thrombocytopenia.

Journal: EJHaem

Published: February 06, 2025

Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study.

Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study.

Journal: The Lancet. Haematology

Published: November 29, 2024

"It's like going through life at a mediocre level": a qualitative study of the meaning and impact of fatigue in children and young people with sickle cell disease.

"It's like going through life at a mediocre level": a qualitative study of the meaning and impact of fatigue in children and young people with sickle cell disease.

Journal: BMC pediatrics

Published: August 26, 2024

Immune thrombocytopenia in Kabuki syndrome, a comparison with non-Kabuki cases in the UK paediatric ITP registry.

Immune thrombocytopenia in Kabuki syndrome, a comparison with non-Kabuki cases in the UK paediatric ITP registry.

Journal: Orphanet journal of rare diseases

Published: July 26, 2024

Caplacizumab in pediatric immune thrombotic thrombocytopenic purpura: the UK TTP Registry experience.

Caplacizumab in pediatric immune thrombotic thrombocytopenic purpura: the UK TTP Registry experience.

Journal: Blood advances

Published: April 24, 2024

Quality of life in childhood immune thrombocytopenia: Revision of the Kids' ITP Tools (KIT).

Quality of life in childhood immune thrombocytopenia: Revision of the Kids' ITP Tools (KIT).

Journal: British journal of haematology

Published: March 21, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026